table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
antiviral and associated therapy
bromhexine Mikhaylov
chloroquine and derivatives
hydroxychloroquine Barnabas RV Grau-Pujol COVID PREP ... COVID PREP HCQ ... HERO-HCQ ... PATCH-cohort 3 PreP ... Raja Abella Bhattacharya Gendelman EPI-PHARE Syed COVID-PEP-Post exposure ... BCN PEP-CoV-2-Study 1 ... Jung EPICOS ... Rojas-Serrano Rentsch Seet ...
ivermectin Behera Seet 2021 Ivercar-Tuc Behera NCT04422561 ... Alam
nirmatrelvir / ritonavir (Paxlovid) EPIC PEP

4 studies excluded by filtering options 2

5521 Del Amo, 2020 200excludedrisk of bias not avaialble
6097 Elgazzar - prophylaxis, 2020 213excludedhigh risk of bias
6374 NCT04425850 (Caravallo), 2020 2310excludednot a RCTrisk of bias not avaialble
10322 Elgazzar, 0 200excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons